- Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq
- Cognos Co-Founder and CIO Josh Shachar Discusses The Evolution of the Cognos Vision
- Cognos Engages Maxim Group for Investment Banking and Financial Advisory Services
- Cognos Announces Addition of New Clean Room To Expand Its Development Capabilites.
- Dr. Susan Alpert, MD, PhD, Joins Cognos Therapeutics as Lead Regulatory Consultant